~~<i id='34AF178086'><strike id='34AF178086'><tt id='34AF178086'><pre id='34AF178086'></pre></tt></strike></i>~~

Home» Wikipedia» entertainment

entertainment

author：comprehensive 2025-10-06 11:07:45 Page View：25

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs
Next article： Psychedelics group wrestles with new pharma identity

explore

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

MoonLake credibility takes another hit with mid

MollyFerguson/STATMoonLakeImmunotherapeutics,aSwissbiotech,wasburiedMondayunderanavalancheofitsownda

23andMe had bad news about my health. I wish a person had delivered it

ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

WuXi Biologics execs register to lobby as Congress comes for the company

AdobeWASHINGTON—WuXiBiologicsexecutiveshavejoinedthelobbyingfrayinthelead-uptoamovebyCongresstoaddth